亚洲社会药学

最多下载

一年内发表文章 | 两年内 | 三年内 | 全部 | 最近1个月下载排行 | 最近1年下载排行

当前位置： 全部

Please wait a minute...


选择: 导出引用 EndNote Ris BibTeX 显示/隐藏图片

Select

1. On Predicting the Price of Chinese Herbal Medicines Based on the Combination Model of ARIMA and GM (1, 1): A Case Study of Panax Notoginseng Wu Wanlin, Wang Shuling 亚洲社会药学

Select

2. Group Purchasing Organizations (GPOs) in the U.S.: Development and Reform Jin Jing, Xiong Jiamei, Yang Yue, Huang Zhe 亚洲社会药学    2019, 14 (3): 100-109.   摘要 （751）      PDF（pc） （2783KB）（5294）    可视化    收藏 Objective To study the characteristics, specific functions and policy improvement process of the Group Purchasing Organizations (GPOs) in the U.S. and to provide references for drug group purchasing practices in China. Methods Domestic and foreign relevant literatures, websites were reviewed or searched to analyze the functions and policy improvement process of the GPOs in the U.S. so as to provide references for drug group purchasing practices in China. Results and Conclusion As a third party in the U.S. GPOs has formed a relatively integrated business process and projects service system after long-term development. Supported by corresponding policies and industrial regulations, GPOs have made a great contribution to control the growth of medical and healthcare expenses and improve the efficiency of medical institutions, and its development experience can enlighten the practices in China. 相关文章 | 多维度评价 | 评论（0）

Select

3. Development of Licensed Pharmacists in China: Dilemma and Opportunity De Xianhui, An Lianyu, Wang Shuling 亚洲社会药学    2019, 14 (4): 192-203.   摘要 （507）      PDF（pc） （1418KB）（5175）    可视化    收藏 Objective To study the current status of licensed pharmacists in China, and to make suggestions for the sound development of regulation authorities and licensed pharmacists. Methods Literature review and data research were conducted to analyze the status of examinations, registration, academic qualification and professional composition of licensed pharmacists. And SWOT method was used to analyze the strengths, weaknesses, opportunities and threats for the development of licensed pharmacists. Results and Conclusion Licensed pharmacists have such advantages and opportunities as professionalism, favorable policies, and continuous expansion of market demand. However, they also face disadvantages and threats, such as low service capacity, weak service awareness and low social status. According to the results of SWOT analysis, it is suggested that the government should make use of the advantages of artificial intelligence to build a regulatory information platform and a public platform for electronic prescriptions. Meanwhile, a national accreditation agency for continuing education should be established, and academic exchanges between regional licensed pharmacists and physicians must be organized regularly. Besides, licensed pharmacists can use mobile phones and other information devices to keep abreast of national policy and new medical information. Therefore, their services will be recognized by the public, thus to protect the drug safety for the public. 相关文章 | 多维度评价 | 评论（0）

Select

4. The Status Quo and Countermeasures of “4+7” Quantity Purchase in China Zhou Yusheng, Wei Xingchen, Piao Huiling, Wang Nan, Wang Xing, Dong Li 亚洲社会药学    2020, 15 (2): 89-96.   摘要 （507）      PDF（pc） （803KB）（4487）    可视化    收藏 Objective To understand the effectiveness and problems of centralized drug procurement in China by analyzing the implementation of the “4+7” pilot work for centralized drug procurement in China. Methods The current situation and existing problems of drug procurement in China were analyzed through the literature research method. Results and Conclusion At present, good social benefits have been achieved for China’s drug procurement through pilot projects in several cities, but there are some serious problems. The proposed countermeasures will help to improve the procurement of pharmaceuticals in China. 相关文章 | 多维度评价 | 评论（0）

Select

5. Analysis of 4,562 Cases of Adverse Drug Reaction/Event Caused by Cefoperazone Sodium and Sulbactam Sodium for Injection Wei Fenfang, Zhang Zhongyi, Zheng Yongxia, Yang Yue 亚洲社会药学

Select

6. Measures to Speed up Drug Review Process in Japan and Its Implications Shi Wenwen, Sun Lihua 亚洲社会药学

Select

7. Project Management of Generic Drug R&D and Registration in the United States Mao Xiaofang, Qi Xiang, Zhou Fengxiang 亚洲社会药学

Select

8. Research on Incentive Policies for Chinese Innovative Drug R&D - Taking Innovative Anti-tumor Drugs as an Example Wang Yuejun, Yang Yue, Huang Zhe 亚洲社会药学    2023, 18 (4): 303-314.   摘要 （186）      PDF（pc） （2658KB）（1721）    可视化    收藏 Objective To provide reference for improving Chinese innovative drug research and development incentive policies. Methods Based on investigating the incentive policies for innovative drug research and development in clinical research, evaluation and approval in China, anti-tumor drugs were taken as the research object to discuss relevant policies from the perspective of clinical trials and registration approval based on data statistics and current situation analysis. Results and Conclusion Driven by a series of incentive policies for innovative drug R&D, great achievements have been made on anti-tumor drugs. However, there are problems such as concentration of drug targets, homogenization of clinical trials, and gaps in some drugs with large clinical needs. To improve incentive policies for innovative drug R&D, China should adhere to the orientation of clinical value, focusing on basic research and translational research, improving evaluation and approval capabilities, and establishing a sound ecosystem for innovative drugs. 相关文章 | 多维度评价 | 评论（0）

Select

9. Current Situation and Development Strategy of Residents’ Cognition and Use of TCM in Liaoning Province Wang Shuling, Ren Zhaoxia, He Yalan 亚洲社会药学    2021, 16 (2): 163-173.   摘要 （500）      PDF（pc） （4509KB）（1636）    可视化    收藏 Objective To investigate and analyze the residents’ cognition and use of traditional Chinese medicine (TCM) and put forward corresponding countermeasures for its existing problems. Methods A questionnaire survey was conducted to investigate the cognition and trust of TCM from 380 residents in Liaoning Province. Then, the differences of residents’ way of purchasing TCM and gaining the knowledge of TCM. Finally, Polygonum multiflorum was taken as an example to analyze the problems in residents’ cognition and use of Chinese medicinal materials, Chinese traditional decoction pieces, and Chinese patent medicine. Results and Conclusion A total of 402 questionnaires were collected, and 380 were valid. The effective rate was 94.53%. Residents’ understanding of the top three TCM processing techniques were simmering (58.95%), baking (56.84%), and parching (45.00%). The top three best-known TCM for them were chrysanthemum (72.63%), tangerine peel (63.16%), and hawthorn (62.11%). The main factors influencing residents’ willingness to purchase TCM were doctors’ advice (52.63%), and experts or experienced people’s suggestion (54.21%). The top three ways of residents’ gaining TCM knowledge were: TCM knowledge lecture (64.21%), health care knowledge (55.79%), and personal experience of Chinese medicine such as acupuncture and cupping (54.21%). However, due to the lack of professional knowledge of TCM, insufficient supervision and inconsistent standards, residents frequently took TCM by mistake. Residents have a high recognition of TCM, so its future development is optimistic. However, some residents’ insufficient knowledge of TCM often leads to the misapplication of the medicine. Therefore, to improve residents’ cognition of TCM, it is not only to actively publicize the professional knowledge of TCM, but also to improve the professional skills of practitioners, and the supervision standards and intensity of TCM market, so as to make residents feel at ease to buy safe and high-quality TCM products. 相关文章 | 多维度评价 | 评论（0）

Select

10. Research on the Status Quo and Optimization of Centralized Procurement of Coronary Stents Zhang Yuting, Liu Xiaoxi 亚洲社会药学    2024, 19 (1): 20-28.   摘要 （173）      PDF（pc） （433KB）（1556）    可视化    收藏 Objective To study the impact of the first national centralized procurement of coronary stents on patients’ psychology, the economy of medical institutions, and the survival and development of the coronary stents industry, and to provide suggestions on perfecting procedures to better carry out the centralized procurement of coronary stents. Methods Literature analysis was used to investigate the results of the procurement of coronary stent in a province and a hospital. Results and Conclusion The centralized procurement of coronary stents has alleviated the economic pressure of patients, but it has many problems. Therefore, this paper proposes some suggestions, such as promoting the orderly development of the coronary stent industry, improving the evaluation link of the centralized procurement of coronary stents, adopting the accurate reporting model to ensure the quality of coronary stents and improving the standardization of clinical services. 相关文章 | 多维度评价 | 评论（0）

Select

11. Application of SWOT Analysis and Porter’s Five Forces Analysis to State-owned Enterprise Affiliated Hospitals in China Wang Tao, Wu Zhi’ang, Li Shuchuen 亚洲社会药学

Select

12. 中國藥品管理未來合理走勢分析 孫利華;劉琰;陶海英    2008, 3 (1): 1-4.   摘要 （2932）      可视化    收藏 目的 為中國醫藥企業宏觀決策提供參考，以促進其健康發展。方法 運用系統觀點和方法，對中國藥品管理的未來走勢進行邏輯推理與分析。結果與結論 中國藥品管理的未來走勢將日趨科學、合理，管理的目標及關鍵要素將日益明瞭，企業應及早順應國家的發展趨勢與要求。 相关文章 | 多维度评价 | 评论（0）

Select

13. Strategic Research on Pharmaceutical Enterprises’Participation in National Drug Centralized Procurement Yang Dianzheng, Xu Wenxiu, Qi Yun, Yang Yue 亚洲社会药学    2022, 17 (1): 15-22.   摘要 （520）      PDF（pc） （958KB）（1369）    可视化    收藏 Objective To study the influence of national drug centralized procurement policy on pharmaceutical enterprises manufacturing generic drugs and original drugs, so as to provide a reference for them to make different strategic choices. Methods Through the literature research on the related policies and the bidding data, the national drug centralized policies were studied systematically. Combined with the bid-winning price and price reduction range of the winning enterprises in the three rounds of centralized procurement, their difficulties, strategic choices and the winning factors were investigated. Besides, a model was established to clarify the optimal price of enterprises in the process of drug procurement. Results and Conclusion The strategic choices of enterprises in participating national drug centralized procurement are influenced by many factors such as the market share of the original varieties, active pharmaceutical ingredients (APIs) and cost. Therefore, corresponding strategies should be formulated according to the characteristics and interests of enterprises. 相关文章 | 多维度评价 | 评论（0）

Select

14. Dynamic Evaluation on Scientific and Technological Innovation Efficiency of Medical Universities in China Tan Xiaodong, Chen Yuwen 亚洲社会药学

Select

15. 藥品註冊中專利鏈接問題的探討 沈晗;徐懷伏    2008, 3 (1): 15-19.   摘要 （2851）      可视化    收藏 目的 完善中國藥品註冊中的專利鏈接制度。方法 從新頒佈的《藥品註冊管理辦法》相關條款出發，分析了中國藥品註冊過程中可能遇到的專利鏈接問題及其原因，並參照美國等制藥強國的相關法規進行比較分析。結果與結論 新辦法加強了對新藥專利的保護，但在藥品註冊中仍存在專利鏈接方面的問題，應通過建立藥品專利資料庫等措施不斷完善，并要結合中國醫藥產業自身特點，對專利鏈接制度進行可行性和可操作性方面的深入研究。 相关文章 | 多维度评价 | 评论（0）

Select

16. 中國醫藥企業戰略聯盟類型選擇 郭瑩 ;劉嬌豔 ;郭晶 ;楊亮    2006, 1 (2): 76-79.   摘要 （2838）      可视化    收藏 目的 通過介紹全球戰略聯盟類型，探討適合中國醫藥企業現階段採取的戰略聯盟類型。方法 通過文獻查閱法，借鑒其他國家的戰略聯盟類型，從而提出適合中國醫藥企業的聯盟類型。結果與結論 對於中國不同類型的醫藥企業，應該分別採取不同的戰略聯盟類型。 相关文章 | 多维度评价 | 评论（0）

Select

17. Present Situation and Enlightenment of Post-Approval Change Management of Drugs in China, USA and EU Lv Xiaowen, Huang Zhe 亚洲社会药学    2023, 18 (1): 17-23.   摘要 （492）      PDF（pc） （358KB）（1327）    可视化    收藏 Objective To provide suggestions for further improvement of China’s drug post-approval change management system. Methods The current legal and regulatory requirements of post-approval change management systems of drugs in USA, EU and China were compared and analyzed. Results and Conclusion The post-approval change management of drugs is an important part of the whole life-cycle management of drugs. However, there are still some problems in China’s current post-approval change management systems. According to the model and requirements of the post-approval change management systems of the USA and EU, this paper proposes the following suggestions for the improvement of China’s post-approval change management system. Firstly, electronic files for licensed products should be created. Then, regulatory standards at the national level must be unified. Lastly, the concept of product life cycle management should be implemented. 相关文章 | 多维度评价 | 评论（0）

Select

18. Analysis of Factors Affecting Online Drug Purchase – Based on Factor Analysis Wang Shuling, Liu Liang, Zhi Yuanyuan 亚洲社会药学    2022, 17 (3): 268-280.   摘要 （377）      PDF（pc） （2843KB）（1322）    可视化    收藏 Objective To explore the factors affecting consumers’ online drug purchases, and construct models of these factors to provide references for the development and popularization of online pharmacies. Methods Through searching, classifying, integrating, and extracting evaluation indexes of online pharmacies in literature, the indexes of factors affecting online drug purchases were initially established. Then SPSS24.0 was used for data analysis, and finally factor analysis was applied for screening and combining the indexes. Results and Conclusion A model of influencing factors for online drug purchases is set up with 4 factors and 14 indexes. Convenient service is the most important factor affecting online drug purchases. Highly educated young people prefer to buy drugs online. At present, online drug purchase is only a supplement to the purchase of drugs in offline pharmacies, and the penetration rate is not high. Online pharmacies should give full play to their advantages in terms of drug types, prices, logistics and after-sales services to make online drug purchases more mainstream. 相关文章 | 多维度评价 | 评论（0）

Select

19. 藥學專業英語教學之我見 闞啟明;趙春傑;付守廷;鄒莉波    2006, 1 (2): 103-105.   摘要 （2890）      可视化    收藏 目的 為滿足藥學工作對專業英語能力的需求以及目前專業英語教學方式改革的迫切需要，本文提出一些觀點。方法 針對專業英語教學方式枯燥無味及學生專業英語思維建立的階段性，本文從專業英語教材選擇、教學方式和方法上提出一些解決方案，希望能夠調動學生的學習積極性，增強自學意識，改善目前專外教學的現狀。結果與結論 提高藥學專業學生的英語水準，培養國際型藥學人才是藥學專業教師的責任和義務。 相关文章 | 多维度评价 | 评论（0）

Select

20. 適應醫藥電子商務發展的企業信息化建設 周瑩 ;陳玉文 ;孟令全 ;沈偉    2006, 1 (2): 98-102.   摘要 （385）      可视化    收藏 目的 探索有利於中國醫藥企業電子商務發展的企業信息化的建設。方法 結合中國醫藥企業信息化建設的實際情況。研究中國醫藥電子商務順利開展所需要的一些條件。結果與結論 中國醫藥企業電子商務的發展應構建一個統一的醫藥電子商務平臺，開發和應用符合醫藥企業發展的信息化產品，建立專門的組織機構和設置信息化主管等。 相关文章 | 多维度评价 | 评论（0）

Select

21. 對GSP存在問題的研究與探討 蔣蓉;梁毅    2006, 1 (2): 80-83.   摘要 （1825）      可视化    收藏 目的 對GSP標準體系中存在的深層次問題進行研究與探討。方法 結合GSP標準和GSP實施過程中出現的問題進行深入分析。結果與結論 GSP標準中存在的深層次問題影響我國GSP工作的深入實施，必須對此進行改進和優化。 相关文章 | 多维度评价 | 评论（0）

Select

22. 中國藥事管理學科發展研究 田麗娟    2006, 1 (2): 90-94.   摘要 （1722）      可视化    收藏 目的 對中國藥事管理學科的發展歷程加以論述，為藥事管理學科的進一步發展提供經驗和參考。方法 文獻研究法。結果與結論 建國以來，中國藥事管理學科的發展雖經歷過挫折，但也取得了前所未有的成績，呈現出一派蓬勃發展的景象。 相关文章 | 多维度评价 | 评论（0）

Select

23. Considerations on the Quality Standards Reflecting the Characteristics of Compound Preparations of Traditional Chinese Medicine Zhao Wei, Wu Zhi’ang 亚洲社会药学    2022, 17 (3): 199-203.   摘要 （281）      PDF（pc） （821KB）（1286）    可视化    收藏 Objective To study the current quality standard of traditional Chinese medicine (TCM) and its limitations in China, and encourage enterprises to take more responsibility to promote the development of this industry. Methods Based on the analysis of the status quo and problems of the quality standard system of TCM, the quality control mode, as well as the problems found in the reevaluation after marketing, some suggestions were put forward for adjusting the current quality standard of TCM. Results and Conclusion Through strengthening the quality control of the source, and under the premise of ensuring the safety, effectiveness and stability of TCM, the quality standards of TCM can be improved greatly. 相关文章 | 多维度评价 | 评论（0）

Select

24. 關於醫藥品牌忠誠度與美譽度的研究 鐘素豔;李敏    2008, 3 (2): 90-93.   摘要 （593）      可视化    收藏 目的 探討提升醫藥品牌的忠誠度與美譽度的對策。方法 從分析醫藥品牌的忠誠度與美譽度對企業價值影響入手得出結論。結果與結論 打造品牌美譽度與忠誠度，為公司的長遠利益與發展做準備，是提升中國制藥企業綜合競爭力的必經之路。 相关文章 | 多维度评价 | 评论（0）

Select

25. 中醫藥現代化研究與複雜適應系統（CAS）理論 張方;潘岩    2006, 1 (2): 71-75.   摘要 （2935）      可视化    收藏 目的 中醫藥現代化研究中涉及到的複雜性問題多數屬於複雜適應系統問題，如方劑系統、臟腑系統等，但目前並沒有被充分理解和認識。本文著重對以上兩者的特性與CAS理論進行對比研究，為運用CAS理論為中醫藥現代化研究思路的創新提供理論依據。方法 對中醫藥現代研究中的複雜性問題與CAS系統特性進行對比研究。結果與結論 中醫藥現代研究中存在大量的CAS問題，可以借鑒CAS理論的思路、方法進行研究。 相关文章 | 多维度评价 | 评论（0）

Select

26. 中國藥品研發創新的動力機制問題及對策建議 施伯琰 ;陳玉文 ;莊丹 ;王英    2006, 1 (2): 87-89.   摘要 （1632）      可视化    收藏 目的 探索參與中國藥品研發創新行為個體動力機制問題，供有關部門參考。方法 借助技術創新動力機制模型，分析了參與藥品研發創新各個行為主體的創新動力情況。結果與結論 提出了影響各個行為個體的動力因素，並就存在的問題提出了相應的改進建議。 相关文章 | 多维度评价 | 评论（0）

Select

27. 中國國家基本藥物制度研究初探 呂恬;邵蓉    2007, 2 (4): 143-147.   摘要 （594）      可视化    收藏 目的 為中國建立與完善國家基本藥物制度提供建議。方法 通過對國家基本藥物制度的介紹，定性分析中國在推行基本藥物制度過程中存在的一些缺陷與不足，並探討相關對策。結果與結論 基本藥物制度建設在中國尚處起步階段，還存在不少問題，國家各有關部門及社會各界應採取相應措施，加快推進國家基本藥物制度的建立與完善。 相关文章 | 多维度评价 | 评论（0）

Select

28. 關於新藥研發項目人力資源管理的探討 邢花;李野;姚建華;劉曉婷    2007, 2 (3): 85-89.   摘要 （2727）      可视化    收藏 目的 加強新藥研發項目人力資源管理，提高研發項目成功率。方法 通過文獻查閱法，剖析了新藥研發項目人力資源管理中存在的問題。結果與結論 就存在的問題提出了有針對性的、操作性強的應對策略。 相关文章 | 多维度评价 | 评论（0）

Select

29. 從天價醫藥費看中國醫療機構中藥師的作用與地位 孫利華;吳春福    2006, 1 (2): 64-66.   摘要 （2697）      可视化    收藏 目的 充分發揮醫療機構中藥師的作用，提升合理用藥水平。方法 將中國醫療機構中藥師的地位、職責與作用與發達國家較為科學合理的模式進行比較和分析。結果與結論 中國醫療機構中的藥師缺乏應有的法律地位，已嚴重制約了其作用的發揮，應及早出臺藥師法。 相关文章 | 多维度评价 | 评论（0）

Select

30. 中國執業藥師資格制度簡介 黃熙熙    2007, 2 (2): 41-44.   摘要 （2383）      可视化    收藏 目的 瞭解中國執業藥師制度的歷史和現狀，為其改革提供思路。方法 通過採用文獻分析，描述了中國執業藥師制度的歷史和現狀。結果與結論 執業藥師制度前景光明。隨著制度的深入推行，執業藥師將會在提供優良藥品和藥學服務的過程中發揮更大的作用。 相关文章 | 多维度评价 | 评论（0）

Select

31. 淺談以市場需求為導向的藥學人才培養策略 張林芝;趙宏格;劉彥    2007, 2 (2): 76-80.   摘要 （2767）      可视化    收藏 目的 通過對藥學類專業畢業生就業形勢的分析，研究與探討高等藥學教育改革過程中確立以市場需求為導向的人才培養策略的必要性以及途徑。方法 運用數字統計方法和文獻法，理論結合實際，以瀋陽藥科大學畢業生就業和人才培養情況為例，闡述了以市場需求為導向的藥學人才培養策略。結果與結論 為適應當前就業形勢的需要和高等藥學教育可持續性發展的需要，應從樹立人才市場競爭觀念入手，調整藥學教育的學科專業結構，加強學校與用人單位之間的合作，加大就業工作領導和投入，營造“全員就業”氛圍，培養適應市場需求的藥學人才。 相关文章 | 多维度评价 | 评论（0）

Select

32. 中藥現代化與藥物創新 武志昂;;畢開順    2006, 1 (2): 67-70.   摘要 （2687）      可视化    收藏 目的 提出在現實條件下，處置中藥現代化與藥物創新關係的策略建議。方法 從探討中藥現代化與藥物創新的關係入手，系統地論述了藥物創新系統的必備要素、各要素之間的相互關係以及藥物創新在中藥現代化系統中的地位和作用。結果與結論 在考慮兩者關係處置策略時，應將藥物創新服務于中藥現代化作為思考問題和二者協調發展的重點和基準，堅持藥物創新服務於中藥現代化戰略遠景的基本原則。 相关文章 | 多维度评价 | 评论（0）

Select

33. 從日本藥事法的修訂談中國境外藥品委託生產 梁毅    2007, 2 (3): 110-112.   摘要 （502）      可视化    收藏 目的 探討中國制藥企業進行境外藥品委託生產的可行性和必要性。方法 對中國和日本等國藥品委託生產監督管理制度以及中外藥品委託生產法規進行對比分析。結果與結論 中國政府和制藥企業應抓住機遇，在藥品境外委託加工中有所作為。 相关文章 | 多维度评价 | 评论（0）

Select

34. 藥物經濟學在加拿大藥品補償決策中的應用 張潔    2006, 1 (2): 84-86.   摘要 （2816）      可视化    收藏 目的 為我國在醫療保險領域引入藥物經濟學提供借鑒。方法 介紹在加拿大安大略省藥品補償決策過程中藥物經濟學的應用情況。結果與結論 雖然安大略省運用藥物經濟學評價工具來指導藥品補償決策的過程中還存在很多問題，但是它的應用框架以及應用思路都值得我們學習和研究。 相关文章 | 多维度评价 | 评论（0）

Select

35. Analysis of Drug Medical Insurance Access Pricing Based on the Perspective of Binary Equilibrium Zhang Junjun, Wang Shuling 亚洲社会药学    2024, 19 (2): 117-125.   摘要 （121）      PDF（pc） （882KB）（1213）    可视化    收藏 Objective To study the influencing factors in the process of national medical insurance negotiation and drug pricing from the dualistic equilibrium perspective, and to provide reference for the harmonious management of drug pricing in China. Methods Through the literature analysis and policy review, the pricing subject, pricing basis and price control system in the pricing process of medical-accessed medicines were analyzed from the perspective of binary equilibrium and harmonious management. Results and Conclusion It is found that four balances in the drug pricing process, two balances in pricing basis and three balances in price control system need to be considered, respectively. Drug pricing is the key content of national medical insurance access, which is also the hotspot of the policy in the pharmaceutical fields in recent years. Drug pricing not only reflects the value of drugs, but also reflects a lot of top-level designs of binary equilibriums in medical insurance policy. While the rational design of drug pricing requires the joint efforts of the government, pharmaceutical companies and relevant experts to comprehensively consider many equilibriums, so as to improve the relevant systems. 相关文章 | 多维度评价 | 评论（0）

Select

36. 中西醫藥學方法論的文化發生學比較 張方    2007, 2 (2): 55-59.   摘要 （549）      可视化    收藏 目的 從文化發生學的研究視角，探討中西醫藥學兩種醫學模式在方法論上存在巨大差異的根源。方法 文化發端的發生學比較和語境化分析。結果和結論 明確了中西醫藥學產生的文化背景截然不同，這是決定了現代西醫藥學的研究手段和方法運用於中醫藥研究中處處受挫的尷尬局面的根本原因。 相关文章 | 多维度评价 | 评论（0）

Select

37. 中國原研藥與仿製藥價格差異研究（英文） 許立平;李野;史錄文;管曉東;韓晟    2009, 4 (4): 167-170.   摘要 （2002）      可视化    收藏 目的 為完善政府原研藥與仿製藥的價格管理工作提供科學參考。方法 計算政府定價模式下原研藥與仿製藥的價格差異倍數，比較典型治療類別和典型劑型的價差。結果與結論 原研藥與仿製藥的平均價格差異倍數為2.75；符合《藥品政府定價辦法》（2000）規定的差價率的藥品只有24%。中國原研藥與仿製藥的價差偏高。建議引入藥物經濟學評價方法，完善藥品集中招標採購制度和報銷制度，逐步縮小原研藥和仿製藥的價差。 相关文章 | 多维度评价 | 评论（0）

Select

38. 適應中國網上藥店發展的醫藥企業電子商務信息平臺的改造 孟令全;周瑩;邢花    2007, 2 (2): 67-71.   摘要 （2343）      可视化    收藏 目的 探索有利於中國網上藥店發展的商務信息平臺建設。方法 借鑒中國電子商務信息平臺發展的經驗，將現有的醫藥電子商務信息平臺改造成為適合網上藥店業務順利開展的商務信息平臺。結果與結論 中國網上藥店商務信息平臺應有醫保支付系統等。 相关文章 | 多维度评价 | 评论（0）

Select

39. 醫藥物流中心配送優化模型設計 傅書勇;孫淑軍    2007, 2 (3): 90-92.   摘要 （2678）      可视化    收藏 目的 設計醫藥物流中心配送優化模型。方法 運用線性規劃理論進行分析。結論與結果 建立滿足未來需求的物流中心配送優化模型及其最優配送量不變的可變因素變化範圍。 相关文章 | 多维度评价 | 评论（0）

Select

40. 醫藥商業賄賂的法律治理 羅冠傑    2007, 2 (4): 148-152.   摘要 （2968）      可视化    收藏 目的 提出完善中國治理醫藥商業賄賂法律的建議，促進中國依法治理醫藥商業賄賂的進程。方法 運用文獻研究法對醫藥商業賄賂的特徵與危害和現行治理醫藥商業賄賂法律的現狀進行分析進而得出相關結論。結果與結論 醫藥商業賄賂具有產生環節廣泛、賄賂手段多樣、危害程度嚴重三大特徵；醫藥商業賄賂危害極其嚴重必須運用法律手段對其進行治理；現行相關法律存在嚴重欠缺無法起到治理醫藥商業賄賂的作用；對中國治理醫藥商業賄賂法律的完善提出一系列具有可操作性的建議。 相关文章 | 多维度评价 | 评论（0）